{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-04-28", "results": { "skip": 0, "limit": 1, "total": 163377 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "10003854", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20140312", "receiptdateformat": "102", "receiptdate": "20140312", "fulfillexpeditecriteria": "2", "companynumb": "US-ABBVIE-14P-163-1203768-00", "duplicate": "1", "reportduplicate": { "duplicatesource": "ABBVIE", "duplicatenumb": "US-ABBVIE-14P-163-1203768-00" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Unevaluable event", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "DEPAKOTE", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "018723", "drugdosageform": "TABLET", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "actiondrug": "4", "openfda": { "application_number": [ "NDA021168", "NDA018723", "NDA019680" ], "brand_name": [ "DEPAKOTE ER", "DEPAKOTE", "DEPAKOTE SPRINKLES" ], "generic_name": [ "DIVALPROEX SODIUM" ], "manufacturer_name": [ "AbbVie Inc." ], "product_ndc": [ "0074-7401", "0074-3826", "0074-7126", "0074-7402", "0074-7325", "0074-6212", "0074-6214", "0074-6215", "0074-7327", "0074-7326", "0074-6114" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DIVALPROEX SODIUM" ], "rxcui": [ "1099563", "1099565", "1099569", "1099571", "1099625", "1099626", "1099678", "1099679", "1099870", "1099871", "1099596", "1099598" ], "spl_id": [ "0ee65b66-ead3-44ef-911f-14965b067903", "7cc3a0b3-93f8-4825-88e1-bf6ddb0db23d", "d038b7e9-b014-4771-93be-90aeeaece03d" ], "spl_set_id": [ "0dc024ce-efc8-4690-7cb5-639c728fccac", "08a65cf4-7749-4ceb-6895-8f4805e2b01f", "4619aff4-0f80-444f-858d-42e4137aa809" ], "package_ndc": [ "0074-3826-13", "0074-3826-11", "0074-7401-13", "0074-7126-13", "0074-7126-53", "0074-7126-11", "0074-7126-72", "0074-7402-13", "0074-6212-13", "0074-6214-13", "0074-6214-53", "0074-6215-13", "0074-6215-53", "0074-7325-13", "0074-7327-13", "0074-7326-13", "0074-6114-13", "0074-6114-11" ], "unii": [ "644VL95AO6" ] } }, { "drugcharacterization": "2", "medicinalproduct": "TEGRETOL", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "openfda": { "application_number": [ "NDA018927", "NDA016608", "NDA020234" ], "brand_name": [ "TEGRETOL", "TEGRETOL XR" ], "generic_name": [ "CARBAMAZEPINE" ], "manufacturer_name": [ "Novartis Pharmaceuticals Corporation" ], "product_ndc": [ "0078-0508", "0078-0509", "0078-0510", "0078-0511", "0078-0512" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CARBAMAZEPINE" ], "rxcui": [ "199378", "308971", "308972", "308976", "308979", "402505", "402506", "866303", "866305", "866307" ], "spl_id": [ "2765f762-2f4e-4a2b-ac10-cf8149d9a38e" ], "spl_set_id": [ "8d409411-aa9f-4f3a-a52c-fbcb0c3ec053" ], "package_ndc": [ "0078-0508-83", "0078-0509-05", "0078-0509-20", "0078-0510-05", "0078-0511-05", "0078-0512-05" ], "nui": [ "N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607" ], "pharm_class_pe": [ "Decreased Central Nervous System Disorganized Electrical Activity [PE]" ], "pharm_class_epc": [ "Mood Stabilizer [EPC]" ], "pharm_class_moa": [ "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]" ], "unii": [ "33CM23913M" ] } }, { "drugcharacterization": "2", "medicinalproduct": "CALCIUM WITH VITAMIN D", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION" }, { "drugcharacterization": "2", "medicinalproduct": "PROLIA", "drugstructuredosagenumb": "60", "drugstructuredosageunit": "003", "drugadministrationroute": "058", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "openfda": { "application_number": [ "BLA125320" ], "brand_name": [ "PROLIA" ], "generic_name": [ "DENOSUMAB" ], "manufacturer_name": [ "Amgen, Inc" ], "product_ndc": [ "55513-710" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "substance_name": [ "DENOSUMAB" ], "rxcui": [ "993452", "993456" ], "spl_id": [ "ccac6498-945e-4b9c-93b3-b3687c1f1ccb" ], "spl_set_id": [ "49e5afe9-a0c7-40c4-af9f-f287a80c5c88" ], "package_ndc": [ "55513-710-01", "55513-710-21" ], "nui": [ "N0000187055", "N0000187054" ], "pharm_class_epc": [ "RANK Ligand Inhibitor [EPC]" ], "pharm_class_moa": [ "RANK Ligand Blocking Activity [MoA]" ], "unii": [ "4EQZ6YO2HI" ] } }, { "drugcharacterization": "2", "medicinalproduct": "DILANTIN", "drugseparatedosagenumb": "3", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "openfda": { "application_number": [ "ANDA084349" ], "brand_name": [ "DILANTIN" ], "generic_name": [ "EXTENDED PHENYTOIN SODIUM" ], "manufacturer_name": [ "Viatris Specialty LLC" ], "product_ndc": [ "58151-110", "58151-118" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "PHENYTOIN SODIUM" ], "rxcui": [ "855671", "855673", "855869", "855871" ], "spl_id": [ "872f23a8-e6a3-4038-922d-0c26fc81d8b3" ], "spl_set_id": [ "86dd27d1-9cee-48ae-b55d-e2d2f7dbc593" ], "package_ndc": [ "58151-118-01", "58151-110-01", "58151-110-10", "58151-110-32", "58151-110-88" ], "unii": [ "4182431BJH" ] } }, { "drugcharacterization": "2", "medicinalproduct": "PRIMIDONE", "drugstructuredosagenumb": "250", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "openfda": { "application_number": [ "ANDA214896", "ANDA084903", "ANDA083551", "ANDA040586", "NDA009170", "ANDA218366", "ANDA040866", "ANDA040862" ], "brand_name": [ "PRIMIDONE", "MYSOLINE" ], "generic_name": [ "PRIMIDONE" ], "manufacturer_name": [ "Advagen Pharma Limited", "Lannett Company, Inc.", "Actavis Pharma, Inc.", "Oxford Pharmaceuticals, LLC", "Bausch Health US, LLC", "Carnegie Pharmaceuticals LLC", "Chartwell RX, LLC", "NorthStar Rx LLC", "TruPharma LLC.", "Amneal Pharmaceuticals LLC", "Amneal Pharmaceuticals of New York LLC", "Dr. Reddy's Laboratories Limited" ], "product_ndc": [ "72888-045", "72888-160", "72888-046", "0527-1231", "0527-1301", "0591-5321", "69584-684", "69584-685", "66490-690", "66490-691", "80005-117", "80005-118", "62135-468", "72603-609", "72603-610", "52817-117", "65162-544", "65162-545", "53746-544", "53746-545", "55111-476", "55111-477" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "PRIMIDONE" ], "rxcui": [ "96304", "198150", "328176", "201747", "207478" ], "spl_id": [ "48453b30-812c-76c6-e063-6394a90ad9a0", "99bd0a67-2742-43dd-9ddc-430b9141c3b1", "dc55f802-2977-4761-b1c5-179c1bd7a336", "86b0848d-c247-4e50-bc01-dce7dc157605", "9d9f03b1-4eb4-4ba5-a357-600e368802c6", "1f77f842-e0b6-4659-beee-0bb01da839e3", "45ae0446-2685-d868-e063-6394a90ab581", "35a3d3c5-7ece-bbd8-e063-6394a90a14aa", "f6667426-b68b-1ac7-e053-2a95a90a905b", "fe35e838-40df-42c2-bcbf-0ed9aa7eaa5b", "574c0bff-04c5-41f0-8d10-315a824d8efd", "6f5c36d3-3f99-803c-5be6-66b2e1058946" ], "spl_set_id": [ "b3b94d2e-6a64-45b7-b0cb-0fde689240d8", "a1a817f7-c190-4825-94eb-442f477187e3", "ae0fa704-818e-4423-8e3a-6cc3390cdd7d", "439096a4-c5d5-4ad8-be9c-238973a3e290", "af593171-dabb-4ea3-b44c-89ed457b2c46", "dc018b1d-72d3-45a2-84ff-cf9499c7ae97", "4a8e309f-d89e-4b1a-abb2-856a66ebbff9", "182a424b-d142-48c9-996b-059c0885f528", "c60b3a92-4404-4a89-b2c5-c23ff72bedad", "02ba0182-0870-4c0d-a814-a1dc427d47b8", "3cdc361a-5558-4341-ad40-f8bc29b4f1ce", "a4f917f4-2aa2-c3ed-071e-232fa0f125e8" ], "package_ndc": [ "72888-045-01", "72888-045-05", "72888-160-30", "72888-160-01", "72888-160-05", "72888-160-00", "72888-046-01", "72888-046-05", "0527-1301-01", "0527-1301-05", "0527-1301-10", "0527-1231-01", "0527-1231-05", "0527-1231-10", "0591-5321-01", "69584-684-10", "69584-684-50", "69584-685-10", "69584-685-50", "66490-690-10", "66490-691-10", "80005-117-11", "80005-117-15", "80005-117-14", "80005-118-11", "80005-118-15", "80005-118-14", "62135-468-90", "72603-609-01", "72603-609-02", "72603-610-01", "52817-117-30", "52817-117-10", "52817-117-50", "65162-544-10", "65162-544-50", "65162-544-11", "65162-545-10", "65162-545-50", "65162-545-11", "53746-544-01", "53746-544-10", "53746-544-05", "53746-545-01", "53746-545-10", "53746-545-05", "55111-477-30", "55111-477-60", "55111-477-01", "55111-477-05", "55111-477-79", "55111-477-78", "55111-476-30", "55111-476-60", "55111-476-01", "55111-476-05", "55111-476-79", "55111-476-78" ], "nui": [ "N0000175753", "N0000008486" ], "pharm_class_epc": [ "Anti-epileptic Agent [EPC]" ], "pharm_class_pe": [ "Decreased Central Nervous System Disorganized Electrical Activity [PE]" ], "unii": [ "13AFD7670Q" ] } } ] } } ] }